P

Inventor

ENGELHARD VICTOR H

US14 patents
⚠️ This page may combine multiple inventors who share the name “ENGELHARD VICTOR H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV LEIDEN

4 patents
US6521598B1Feb 18, 2003

H-Y antigen

UNIV LEIDEN5 citations72
US7008922B2Mar 7, 2006

H-Y antigen

UNIV LEIDEN3 citations61
US6878375B1Apr 12, 2005

HA-1 antigen

UNIV LEIDEN3 citations61
US7205119B2Apr 17, 2007

HA-1 antigen

UNIV LEIDEN0 citations50

UNIV VIRGINIA PATENT FOUNDATION

3 patents
US10654908B2May 19, 2020

Isolated T cell receptors and methods of use therefor

UNIV VIRGINIA PATENT FOUNDATION4 citations67
US12042530B2Jul 23, 2024

Target peptides for immunotherapy and diagnostics

UNIV VIRGINIA PATENT FOUNDATION0 citations56
US11987613B2May 21, 2024

Isolated T cell receptors and methods of use therefor

UNIV VIRGINIA PATENT FOUNDATION0 citations55

UNIV VIRGINIA

2 patents
US6558671B1May 6, 2003

Cysteine-depleted peptides recognized by A3-restricted cytotoxic lymphocytes, and uses therefor

UNIV VIRGINIA25 citations89
US7019112B1Mar 28, 2006

Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytoxic lymphocytes, and uses therefor

UNIV VIRGINIA12 citations78

U VA LICENSING & VENTURES GROUP

1 patent
US9561266B2Feb 7, 2017

Target peptides for immunotherapy and diagnostics

U VA LICENSING & VENTURES GROUP5 citations74

RIJSUNIVERSITEIT TE LEIDEN

1 patent
US5770201AJun 23, 1998

HA-2 antigenic peptide

RIJSUNIVERSITEIT TE LEIDEN13 citations68

SLINGLUFF JR CRAIG L

1 patent
US9345755B2May 24, 2016

Composition and methods for treating melanoma

SLINGLUFF JR CRAIG L3 citations63

Univ Virginia Patent Found

1 patent
US8012484B2Sep 6, 2011

Method of treating ischemia reperfusion injury by inhibiting NKT cell activity

Univ Virginia Patent Found3 citations56

TOPALIAN SUZANNE L

1 patent
US9279011B2Mar 8, 2016

Phosphopeptides as melanoma vaccines

TOPALIAN SUZANNE L0 citations39